Kimia Biosciences Ltd.
Kimia Biosciences
₹ 0.00
0.00 (0.00)%
NSE
BSE
Healthcare
Small-cap - With a market cap of ₹1.67 Cr.
| EX-Date | Purpose |
|---|---|
| 22 06 2021 | Audited Results |
| 12 08 2021 | Quarterly Results |
| 11 11 2021 | Quarterly Results |
| 14 02 2022 | Quarterly Results |
| 30 05 2022 | Audited Results |
| 12 08 2022 | Quarterly Results |
| 14 11 2022 | Quarterly Results |
| 14 02 2023 | Quarterly Results |
| 30 05 2023 | Audited Results |
| 14 08 2023 | Quarterly Results |
| 09 11 2023 | Quarterly Results |
| 14 02 2024 | Quarterly Results |
| 14 11 2024 | Quarterly Results |
| 05 12 2024 | A.G.M. |
| 13 02 2025 | Quarterly Results |
| 23 04 2025 | Inter alia, to transact the following businesses, amongst others: 1) To consider and short listing the firm for appointment of Statutory Auditors of the Company arose due to casual vacancy. 2) To take note of Resignation of Chief Finance officer. 3) Any other matter as may be considered and transacted with permission of Board of Directors. |
| 05 05 2025 | Inter alia, to transact the following businesses, amongst others:- 1) Payment to Redeemable Preference Shares. 2) Any other matter may be considered and transacted with the permission of Board ofDirectors. |
| 26 05 2025 | Audited Results |
| 14 08 2025 | Quarterly Results |
| 29 08 2025 | A.G.M. Inter alia, to consider and approve:- 1. Approval of Annual Report 2. Approval of notice of 32nd AGM 3. Fixation of day, date and time of 32nd AGM 4. Appointment of Mr. Harish Kumar, Proprietor of Harish Kumar & Associates, Practicing Company Secretary as Scrutinizer for remote e-voting 5. Appointment of Mr. Harish Kumar, Proprietor of Harish Kumar & Associates, Practicing Company Secretary as Secretarial Auditor of the Company for 5 years 6. Appointment of Neeraj Arora & Associates, Chartered Accountants as Statutory Auditors for 5 years 7. Re-appointment of Mr. Sameer Goel who is liable to retire by rotation 8. Approval of remuneration of Cost Auditors 9. Any other matter with the permission of Chair |
| 14 11 2025 | Quarterly Results |
| 14 02 2026 | Quarterly Results |
